90 results
8-K
EBS
Emergent Biosolutions Inc
12 Aug 10
Other Events
12:00am
been FORMULATED for both intravenous infusion AND s.c. administration.
Patient dosing has commenced and recruitment is currently underway in a Phase 2 … trial of SBI-087 for RA evaluating the safety and efficacy of subcutaneous administration of 200mg of SBI-087.
In addition, patient recruitment
425
EBS
Emergent Biosolutions Inc
16 Aug 10
Business combination disclosure
12:00am
anti-CDZO therapeutics.
Patient dosing has commenced and recruitment is currently underway in a Phase 2 trial of SBI-087 for RA evaluating the safety … and efficacy at subcutaneous administration of 200mg of the drug.
In addition, patient recruitment is ongoing in a Phase 1 trial of SBI-087 for RA
425
TRBN
Trubion Pharmaceuticals Inc
12 Aug 10
Business combination disclosure
12:00am
been FORMULATED for both intravenous infusion AND s.c. administration.
Patient dosing has commenced and recruitment is currently underway in a Phase 2 … trial of SBI-087 for RA evaluating the safety and efficacy of subcutaneous administration of 200mg of SBI-087.
In addition, patient recruitment
8-K
EX-99.1
EBS
Emergent Biosolutions Inc
8 Nov 22
Emergent Biosolutions Reports Financial Results for Third Quarter 2022
4:52pm
-dose CHIKV VLP vaccine candidate in adults aged 12 to 64; recruitment continues for the second Phase 3 study focused on adults 65 and older.
1 of 16
S-4
pjlhq9opefq
13 Sep 10
Registration of securities issued in business combination transactions
12:00am
424B3
v5t5 lz8nhe0h
23 Sep 10
Prospectus supplement
12:00am
S-4/A
naag4dikz7 0q0
23 Sep 10
Registration of securities issued in business combination transactions (amended)
12:00am
10-K
hjxzuqj 16cbrwc6d
27 Mar 07
Annual report
12:00am